Inclusion |
■ Age: ≥18 years of age |
- Women: Pre-menopausal (self-report) and ≤50 years of age |
- Men: ≤50 years of age |
■ Race/Ethnicity: All |
■ BMI (body mass index): 28-40 kg/m2 (Measured in clinic) |
■ Body weight stable for the last two months, and not actively on a weight loss plan |
■ No plans to move from the area over the next 12 months from start of study cohort |
■ Available and able to participate in the evaluations and intervention for the study period |
■ Willing to accept random assignment |
■ To enhance study generalizability, people on medications not noted below as specific exclusions can participate if they have been stable on such medications for at least three months |
■ Ability and willingness to give written informed consent |
■ No known active psychiatric illness |
Exclusion |
■ Pregnant, lactating, within 6 months post-partum, or planning to become pregnant in the next year |
■ Diabetes (type 1 and 2) or history of gestational diabetes or on hypoglycemic medications for any other indication |
■ Prevalent diseases: Malabsorption, renal or liver disease, active neoplasms, recent myocardial infarction (<6 months) |
■ Currently smoking |
■ History of serious arrhythmias, or cerebrovascular disease |
■ History of Bariatric Surgery |
■ Uncontrolled hyper- or hypothyroidism (TSH not within normal limits, self-report) |
■ Medications: Lipid lowering, antihypertensive medications, and those known to affect weight/energy expenditure |
■ Excessive alcohol intake (self-reported, ≥ to 2 drinks/day for men or ≥1 drink/day for women) |
■ Musculoskeletal disorders precluding regular physical activity |
■ Unable to follow either of the two study diets for reasons of food restrictions (e.g., vegan) |
■ Currently under psychiatric care, or taking psychiatric medications |
■ Inability to communicate effectively with study personnel |